Hai V Tran
Examiner (ID: 9064, Phone: (571)270-7650 , Office: P/2845 )
Most Active Art Unit | 2845 |
Art Unit(s) | 2611, 2845, 2426, 4100, 2711, 2623, 2423, 2491, 2821 |
Total Applications | 1291 |
Issued Applications | 923 |
Pending Applications | 111 |
Abandoned Applications | 257 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18691014
[patent_doc_number] => 20230321199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
[patent_app_type] => utility
[patent_app_number] => 18/320638
[patent_app_country] => US
[patent_app_date] => 2023-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18320638
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/320638 | USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK | May 18, 2023 | |
Array
(
[id] => 18753968
[patent_doc_number] => 20230357322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => METHOD OF MANUFACTURING A PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/142470
[patent_app_country] => US
[patent_app_date] => 2023-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18142470
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/142470 | METHOD OF MANUFACTURING A PHARMACEUTICAL COMPOSITION | May 1, 2023 | Pending |
Array
(
[id] => 18806950
[patent_doc_number] => 20230381283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
[patent_app_type] => utility
[patent_app_number] => 18/296801
[patent_app_country] => US
[patent_app_date] => 2023-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296801
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296801 | USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK | Apr 5, 2023 | Pending |
Array
(
[id] => 18596125
[patent_doc_number] => 20230270916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => COLLAGEN COMPOSITIONS AND USES FOR BIOMATERIAL IMPLANTS
[patent_app_type] => utility
[patent_app_number] => 18/121384
[patent_app_country] => US
[patent_app_date] => 2023-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24850
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18121384
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/121384 | COLLAGEN COMPOSITIONS AND USES FOR BIOMATERIAL IMPLANTS | Mar 13, 2023 | Pending |
Array
(
[id] => 18581607
[patent_doc_number] => 20230263859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => SILK-BASED PRODUCT FORMULATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/176903
[patent_app_country] => US
[patent_app_date] => 2023-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 132175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176903
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/176903 | SILK-BASED PRODUCT FORMULATIONS AND METHODS OF USE | Feb 28, 2023 | Pending |
Array
(
[id] => 18737988
[patent_doc_number] => 20230346891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => STABLE THERAPEUTIC COMPOSITIONS IN APROTIC POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/168438
[patent_app_country] => US
[patent_app_date] => 2023-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18168438
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/168438 | Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same | Feb 12, 2023 | Issued |
Array
(
[id] => 18752280
[patent_doc_number] => 20230355499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => COMPOSITION FOR IMPROVING HAIR HEALTH
[patent_app_type] => utility
[patent_app_number] => 18/164515
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164515
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/164515 | COMPOSITION FOR IMPROVING HAIR HEALTH | Feb 2, 2023 | Pending |
Array
(
[id] => 18420523
[patent_doc_number] => 20230174985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/102415
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102415
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/102415 | MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS | Jan 26, 2023 | Pending |
Array
(
[id] => 18692577
[patent_doc_number] => 20230322878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/152624
[patent_app_country] => US
[patent_app_date] => 2023-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 129991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18152624
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/152624 | COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF | Jan 9, 2023 | Pending |
Array
(
[id] => 18363062
[patent_doc_number] => 20230144653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => 1,2,4-Oxadiazole Compounds as Inhibitors of CD47 Signalling Pathways
[patent_app_type] => utility
[patent_app_number] => 18/150246
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150246
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150246 | 1,2,4-Oxadiazole Compounds as Inhibitors of CD47 Signalling Pathways | Jan 4, 2023 | Pending |
Array
(
[id] => 18612313
[patent_doc_number] => 20230279045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => METHODS AND SYSTEMS FOR SOLID PHASE PEPTIDE SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 18/068838
[patent_app_country] => US
[patent_app_date] => 2022-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18068838
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/068838 | METHODS AND SYSTEMS FOR SOLID PHASE PEPTIDE SYNTHESIS | Dec 19, 2022 | Pending |
Array
(
[id] => 19226711
[patent_doc_number] => 12006344
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => MIC-1 compounds and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/083811
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 15198
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18083811
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/083811 | MIC-1 compounds and use thereof | Dec 18, 2022 | Issued |
Array
(
[id] => 18597271
[patent_doc_number] => 20230272066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => TARGETING MODULES FOR UNIVERSAL CHIMERIC ANTIGEN RECEPTOR EXPRESSING IMMUNE CELLS AND USE IN THE TREATMENT OF CANCER, INFECTIONS AND AUTOIMMUNE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/084155
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18084155
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/084155 | TARGETING MODULES FOR UNIVERSAL CHIMERIC ANTIGEN RECEPTOR EXPRESSING IMMUNE CELLS AND USE IN THE TREATMENT OF CANCER, INFECTIONS AND AUTOIMMUNE DISORDERS | Dec 18, 2022 | Pending |
Array
(
[id] => 18738038
[patent_doc_number] => 20230346947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVITY OF LAR FAMILY PHOSPHATASES
[patent_app_type] => utility
[patent_app_number] => 17/987137
[patent_app_country] => US
[patent_app_date] => 2022-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17987137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/987137 | COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVITY OF LAR FAMILY PHOSPHATASES | Nov 14, 2022 | Pending |
Array
(
[id] => 18869823
[patent_doc_number] => 11857603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => PTH compounds with low peak-to-trough ratios
[patent_app_type] => utility
[patent_app_number] => 18/053701
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34631
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053701
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053701 | PTH compounds with low peak-to-trough ratios | Nov 7, 2022 | Issued |
Array
(
[id] => 18323921
[patent_doc_number] => 20230122049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => METHOD AND COMBINATION FOR THE SUPPRESSION OF COVID-19 VIRUS
[patent_app_type] => utility
[patent_app_number] => 18/048262
[patent_app_country] => US
[patent_app_date] => 2022-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048262
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/048262 | METHOD AND COMBINATION FOR THE SUPPRESSION OF COVID-19 VIRUS | Oct 19, 2022 | Pending |
Array
(
[id] => 18309917
[patent_doc_number] => 20230113817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF FOR FAT LOSS
[patent_app_type] => utility
[patent_app_number] => 17/964903
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17964903
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/964903 | DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF FOR FAT LOSS | Oct 11, 2022 | Pending |
Array
(
[id] => 18947042
[patent_doc_number] => 11890315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Stable ascorbic acid compositions and methods of using same
[patent_app_type] => utility
[patent_app_number] => 17/938861
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 24312
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17938861
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/938861 | Stable ascorbic acid compositions and methods of using same | Oct 6, 2022 | Issued |
Array
(
[id] => 18389909
[patent_doc_number] => 20230158127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/932230
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17932230
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/932230 | COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES | Sep 13, 2022 | Pending |
Array
(
[id] => 18374426
[patent_doc_number] => 20230149505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => HMGB1 ANTAGONIST TREATMENT OF SEVERE SEPSIS
[patent_app_type] => utility
[patent_app_number] => 17/898994
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 535
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/898994 | HMGB1 antagonist treatment of severe sepsis | Aug 29, 2022 | Issued |